Macter International Limited (PSX:MACTER)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
338.07
+2.49 (0.74%)
At close: Dec 5, 2025
19.24%
Market Cap 15.49B
Revenue (ttm) 10.96B
Net Income (ttm) 834.71M
Shares Out 45.81M
EPS (ttm) 18.22
PE Ratio 18.56
Forward PE n/a
Dividend 3.80 (1.13%)
Ex-Dividend Date Oct 16, 2025
Volume 7,050
Average Volume 26,936
Open 338.99
Previous Close 335.58
Day's Range 336.01 - 340.00
52-Week Range 248.00 - 621.82
Beta 0.09
RSI 40.91
Earnings Date Feb 17, 2026

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1992
Employees 1,282
Stock Exchange Pakistan Stock Exchange
Ticker Symbol MACTER
Full Company Profile

Financial Performance

In 2025, Macter International's revenue was 10.36 billion, an increase of 29.91% compared to the previous year's 7.97 billion. Earnings were 776.43 million, an increase of 90.91%.

Financial Statements

News

There is no news available yet.